Anika Therapeutics Inc (ANIK)

SG&A Expense Growth

-38.39%

Quarterly · Period ending:

ANIK logo

ANIK SG&A Expense Growth

Latest reported-38.39%
ANIK Quarterly SG&A Growth (QoQ) (0.00% → -38.39%)
High-resolution chart · PNG

ANIK sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-38.3919%
47.107%
1.769%
-2.9354%
-5.2379%
363.9264%
-125.586%
22.3795%
-27.4539%
5.8618%
-18.0932%
4.8039%
-12.25%
17.1244%
8.3333%
0.0376%
10.7651%
-6.0249%
16.7543%
-2.7183%
-1.0234%
19.7378%
-4.5526%
9.299%
0.8246%
17.9292%
62.316%
0.4932%
-2.2158%
25.1754%
7.5263%
-11.1734%
-60.1181%
140.9404%
38.4615%
-2.9968%
-1.8749%
-7.6713%
28.2243%
0.5875%
6.6416%
-11.8037%
36.7292%
-2.3539%
-5.9969%
-1.8361%
-9.2088%
4.6215%
10.7388%
45.4857%
-24.7479%
-6.2343%
-13.8439%
7.6269%
1.8233%
-12.3346%
22.6047%
-31.1806%
3.3342%
11.3117%
4.6873%
-2.6276%
6.2542%
-21.3171%
15.8165%
122.0168%
-32.0495%
3.9275%
-9.866%
23.8909%
-4.5687%
-10.8729%
-6.1415%
6.378%
58.4095%
6.1126%
8.9552%
7.891%
0.4445%
-26.47%
10.4863%
43.2346%
-10.3374%
-5.5593%
14.1641%
-30.9091%
28.3459%
3.5537%
7.5688%
3.481%
42.8249%
-6.3492%
-15.2466%
5.5431%
17.3572%
-35.1838%
28.6562%
-42.1455%
69.5977%
-40.812%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.